3025 related articles for article (PubMed ID: 32311448)
1. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
Bikdeli B; Madhavan MV; Jimenez D; Chuich T; Dreyfus I; Driggin E; Nigoghossian C; Ageno W; Madjid M; Guo Y; Tang LV; Hu Y; Giri J; Cushman M; Quéré I; Dimakakos EP; Gibson CM; Lippi G; Favaloro EJ; Fareed J; Caprini JA; Tafur AJ; Burton JR; Francese DP; Wang EY; Falanga A; McLintock C; Hunt BJ; Spyropoulos AC; Barnes GD; Eikelboom JW; Weinberg I; Schulman S; Carrier M; Piazza G; Beckman JA; Steg PG; Stone GW; Rosenkranz S; Goldhaber SZ; Parikh SA; Monreal M; Krumholz HM; Konstantinides SV; Weitz JI; Lip GYH;
J Am Coll Cardiol; 2020 Jun; 75(23):2950-2973. PubMed ID: 32311448
[TBL] [Abstract][Full Text] [Related]
2. [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care].
Piera Carbonell A; Frías Vargas M; García Vallejo O; García Lerín A; Cabrera Ferriols MA; Peiró Morant J; Carrasco Carrasco E;
Semergen; 2020 Oct; 46(7):479-486. PubMed ID: 33046353
[TBL] [Abstract][Full Text] [Related]
3. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection.
Llau JV; Ferrandis R; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A; Quintana M; Amezaga R; Gero M; Serrano A; Marcos P
Rev Esp Anestesiol Reanim (Engl Ed); 2020; 67(7):391-399. PubMed ID: 32591185
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
McFadyen JD; Stevens H; Peter K
Circ Res; 2020 Jul; 127(4):571-587. PubMed ID: 32586214
[TBL] [Abstract][Full Text] [Related]
5. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
[TBL] [Abstract][Full Text] [Related]
6. COVID-19-associated coagulopathy.
Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolic events in patients with SARS-CoV-2.
Ng JJ; Choong AMTL
J Vasc Surg; 2020 Aug; 72(2):760-761. PubMed ID: 32360371
[No Abstract] [Full Text] [Related]
8. Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
Ornelas-Ricardo D; Jaloma-Cruz AR
Tohoku J Exp Med; 2020 Aug; 251(4):327-336. PubMed ID: 32788506
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Bikdeli B; Madhavan MV; Gupta A; Jimenez D; Burton JR; Der Nigoghossian C; Chuich T; Nouri SN; Dreyfus I; Driggin E; Sethi S; Sehgal K; Chatterjee S; Ageno W; Madjid M; Guo Y; Tang LV; Hu Y; Bertoletti L; Giri J; Cushman M; Quéré I; Dimakakos EP; Gibson CM; Lippi G; Favaloro EJ; Fareed J; Tafur AJ; Francese DP; Batra J; Falanga A; Clerkin KJ; Uriel N; Kirtane A; McLintock C; Hunt BJ; Spyropoulos AC; Barnes GD; Eikelboom JW; Weinberg I; Schulman S; Carrier M; Piazza G; Beckman JA; Leon MB; Stone GW; Rosenkranz S; Goldhaber SZ; Parikh SA; Monreal M; Krumholz HM; Konstantinides SV; Weitz JI; Lip GYH;
Thromb Haemost; 2020 Jul; 120(7):1004-1024. PubMed ID: 32473596
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives.
Rodriguez JJ; Munoz OC; Porres-Aguilar M; Mukherjee D
Cardiovasc Hematol Disord Drug Targets; 2021; 21(1):23-29. PubMed ID: 33719953
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.
Hashemi A; Madhavan MV; Bikdeli B
Semin Thromb Hemost; 2020 Oct; 46(7):789-795. PubMed ID: 32820478
[No Abstract] [Full Text] [Related]
12. Coagulopathy of Coronavirus Disease 2019.
Iba T; Levy JH; Levi M; Connors JM; Thachil J
Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Ahmed S; Zimba O; Gasparyan AY
Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
[TBL] [Abstract][Full Text] [Related]
14. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.
Watson RA; Johnson DM; Dharia RN; Merli GJ; Doherty JU
Hosp Pract (1995); 2020 Oct; 48(4):169-179. PubMed ID: 32429774
[TBL] [Abstract][Full Text] [Related]
15. Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.
Desborough MJR; Doyle AJ; Griffiths A; Retter A; Breen KA; Hunt BJ
Thromb Res; 2020 Sep; 193():1-4. PubMed ID: 32485437
[TBL] [Abstract][Full Text] [Related]
16. Management of Thrombotic Complications in COVID-19: An Update.
Hajra A; Mathai SV; Ball S; Bandyopadhyay D; Veyseh M; Chakraborty S; Lavie CJ; Aronow WS
Drugs; 2020 Oct; 80(15):1553-1562. PubMed ID: 32803670
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
18. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge.
Violi F; Pastori D; Cangemi R; Pignatelli P; Loffredo L
Thromb Haemost; 2020 Jun; 120(6):949-956. PubMed ID: 32349133
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 coagulopathy: an evolving story.
The Lancet Haematology
Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
[No Abstract] [Full Text] [Related]
20. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.
Godoy LC; Goligher EC; Lawler PR; Slutsky AS; Zarychanski R
CMAJ; 2020 Oct; 192(40):E1156-E1161. PubMed ID: 32816822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
